Clinical Trial Update: Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

View source ↗

Summary

This clinical trial update investigates whether prothrombin fragments 1+2 can prognosticate the incidence of pulmonary embolism, with the study (NCT01078792) sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease
• Pulmonary Embolism

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Pulmonary Disease, Chronic Obstructive, Disease Exacerbation | Status: UNKNOWN